The new effort, which relies on money approved by Congress as part of President Joe Biden’s coronavirus relief package, aims to break what experts say is a feast-or-famine cycle in U.S. preparedness for biological threats, of which the coronavirus is only one example.
Nearly half of American adults have gotten at least one dose of the vaccine, and about 30% of adults in the U.S. have been fully vaccinated, according to the Centers for Disease Control and Prevention.
But the shifting age demographics of new infections suggests the virus is still spreading among younger Virginians who aren’t yet eligible for the vaccine — or who weren’t prioritized in the initial phases of the state’s rollout.
In Virginia, there’s growing concern that burnout and extreme stress could lead more providers to leave the field or grapple with long-term mental health problems. On a systemic level, there’s worry that COVID-19 could make an existing physician shortage worse.
As many as 60 countries might be stalled at the first shots of their coronavirus vaccinations because nearly all deliveries through the global program intended to help some of the world's poorest nations are blocked until as late as June.
World Health Organization Director-General Tedros Adhanom Ghebreyesus said that on average, one in four people in rich countries has received at least one dose of a COVID-19 vaccine, compared to only one in 500 people in low-income countries.
A patchwork of advice was emerging from governments across Europe and farther afield, a day after the European Union’s drug regulator said there was a “possible link” between the AstraZeneca vaccine and a rare clotting disorder while reiterating the vaccine is safe and effective.
The CDC is reporting many outbreaks in younger people are being linked to youth sports and extra curriculars. In a White House briefing Monday, CDC Director Dr. Rochelle Wolensky said those activities should be limited.
Any further doubts about the AstraZeneca vaccine would be a setback for the shot, which is critical to Europe’s immunization campaign and a linchpin in the global strategy to get vaccines to poorer countries.